Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Gilead Sciences, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 92.53||$ 123.37|
|Low||$ 87.80||$ 81.89|
The current last sale of $88.21 is 7.72% Higher thanthe 52 week low.
ETFs with GILD as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.06%||iShares Nasdaq Biotechnology Index Fund (IBB)||-63.77 (-19.22%)|
|5.28%||PowerShares Dynamic Biotech &Genome (PBE)||-10.97 (-21.81%)|
|5.21%||SPDR Select Sector Fund - Health Care (XLV)||-1.99 (-2.77%)|
|4.92%||iShares U.S. Healthcare ETF (IYH)||-6.28 (-4.16%)|
|4.81%||Vanguard Health Care ETF - DNQ (VHT)||-5.47 (-4.13%)|
Company Description (as filed with the SEC)
Gilead Sciences, Inc. (Gilead, we or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's primary areas of focus include human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, cardiovascular, hematology/oncology and inflammation/respiratory. We have operations in more than 30 countries worldwide, with headquarters in Foster City, California. We continue to add to our existing portfolio of products through our internal discovery and clinical development programs and through a product acquisition and in-licensing strategy. ... More ...
Where does GILD fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$12.45|
|Quarterly EPS Est:||3.06|